Change in the total number of shares and votes in Recipharm AB (publ)

As of 29 February 2016, the total number of shares in Recipharm AB (publ) (“Recipharm”) amounts to 48,575,256 shares, divided into 12,685,716 shares of series A; 35,389,540 shares of series B and 500,000 shares of series D. The total number of votes in Recipharm as of 29 February 2016 amounts to 162,746,700.

The number of shares and votes in Recipharm has increased as a result of the issue of 2,250,000 new shares of series B directed to a limited number of well-known institutional investors, as previously announced.

For further information please visit www.recipharm.com or contact:
Thomas Eldered, CEO, telephone: +46 8 602 52 10
Björn Westberg, CFO, ir@recipharm.com, telephone: +46 8 602 46 20

This information is published in accordance with Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act (SFS 1991:980).This information was submitted for publication on 29 February 2016, at 08:00 am CET.

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03
www.recipharm.com